Photobiomodulation works by using infrared radiation to treat brain tissue affected by oxygen deprivation, toxic environments, and mitochondrial dysfunction. Mitochondria, which are responsible for producing energy in cells, play a critical role in regulating cellular function when they operate correctly.
Photobiomodulation helps reduce cell damage and neuronal death by protecting dopamine-producing neurons. It has been shown to reduce tissue inflammation and improve mitochondrial function.
This is not a targeted therapy, as it addresses the neural symptoms of many conditions by mitigating the neurodegenerative process. Transcranial photobiomodulation focuses on the brain and is therefore likely to influence multiple facets of neural functioning. Studies have shown improvements in cognitive, emotional, and executive functions.
Photobiomodulation refers to the ability of light to modulate biological processes at the cellular level. Controlled exposure to red and infrared wavelengths of light has successfully enhanced healing, reduced inflammation and pain, improved mitochondrial function, and stimulated antioxidant pathways in the brain.
Photobiomodulation has been therapeutically effective in improving recovery rates for other medical conditions and has shown promise in laboratory studies for humans and animals with Parkinson’s disease.